Betta Pharmaceuticals Co., Ltd.
SZSE:300558.SZ
Overview | Financials
Company Name | Betta Pharmaceuticals Co., Ltd. |
Symbol | 300558.SZ |
Currency | CNY |
Price | 56.19 |
Market Cap | 23,514,729,239 |
Dividend Yield | 0.17% |
52-week-range | 42.5 - 74.83 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Lieming Ding |
Website | https://www.bettapharma.com |
An error occurred while fetching data.
About Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD